CXCL9 and neoplasm: Therefore, the promotion of STAT‐5 signalling might not only promote CXCR3 expression and the homing of CAR T cells to CXCL9/10‐expressing tumours, but also contribute to the acquisition of CTL activity probably through the induction of T‐bet and thereby CAR T‐cell function.